Answers are grounded in this paper and cite their sources.
Modeling compares antibiotic strategies to reduce gonorrhea infections, suggesting informed rollout is crucial.
Numerous factors may influence the optimal rollout of new gonococcal antibiotics. We compared eight rollout strategies using a gonorrhea transmission model and ranked strategies by the number of gonococcal infections and clinically useful antibiotic lifespan. Rankings were most sensitive to the starting ceftriaxone resistance prevalence and screening frequency.
No takes yet. Share an insight, caveat, or question.
Roster et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: